Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Synergistic Effect Of TGF-beta Blockade and Immunogenic Agents on Tumors

  • Read more about Synergistic Effect Of TGF-beta Blockade and Immunogenic Agents on Tumors
Canada
2598090
Filed on 2006-02-16

Synergistic Effect Of TGF-beta Blockade and Immunogenic Agents on Tumors

  • Read more about Synergistic Effect Of TGF-beta Blockade and Immunogenic Agents on Tumors
Australia
2006214052
Filed on 2006-02-16

METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS

  • Read more about METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS
US Patent 8,110,352
Filed on 2006-02-10

METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS

  • Read more about METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS
Japan
2007-555317
Filed on 2007-10-09

METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS

  • Read more about METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS
European Patent
06734945.6
Filed on 2006-02-10

METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS

  • Read more about METHOD OF DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS
Canada
2596845
Filed on 2006-02-10

DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS

  • Read more about DIAGNOSING AND TREATING CANCER USING B-CATENIN SPLICE VARIANTS
Australia
2006213610
Filed on 2006-02-10

INHIBITION OF CELL MOTILITY, ANGIOGENESIS, AND METASTASIS

  • Read more about INHIBITION OF CELL MOTILITY, ANGIOGENESIS, AND METASTASIS
Patent Cooperation Treaty
PCT/US2007/078494
Filed on 2007-09-14

Adjuvant Activity Of Synthetic Oligonucleotide Containing Immunostimulatory CpG Moieties Spontaneously Complexed With Inactivated Whole Viruses

  • Read more about Adjuvant Activity Of Synthetic Oligonucleotide Containing Immunostimulatory CpG Moieties Spontaneously Complexed With Inactivated Whole Viruses
Patent Cooperation Treaty
PCT/US07/002907
Filed on 2007-02-01

Anti-H5N1 Influenza Activity Of The Antiviral Protein Cyanovirin-N (CV-N)

  • Read more about Anti-H5N1 Influenza Activity Of The Antiviral Protein Cyanovirin-N (CV-N)
Patent Cooperation Treaty
PCT/US2007/076181
Filed on 2007-08-17

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 918
  • Page 919
  • Page 920
  • Page 921
  • Page 922
  • Page 923
  • Page 924
  • Page 925
  • Page 926
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health